Beactica Advances BEA-17 Toward Glioblastoma Trials
Uppsala, Sweden, September 22, 2026 Beactica Therapeutics AB has announced the initiation of IND-enabling studies for BEA-17, its wholly...
IND-enabling studies
Advertisement
Sunshine Biopharma Advances PLpro Inhibitor Toward IND
FORT LAUDERDALE, Fla. — September 16, 2026 Sunshine Biopharma Inc. announced that it has advanced its lead Coronavirus drug...
Moonwalk Biosciences Raises $70 Million Series B
SOUTH SAN FRANCISCO and SAN DIEGO — September 8, 2026 Moonwalk Biosciences announced the closing of an oversubscribed $70...
MIRA Pharmaceuticals Advances MIRA-55 Toward Q1 2027 IND
MIAMI, September 1, 2026 MIRA Pharmaceuticals, Inc. has reported positive results from completed 7-day dose-range finding toxicology and toxicokinetic...
Hyperfine Gains FDA Clearance for Next Optive AI Software
Guilford, Connecticut, August 20, 2026 Hyperfine announced that the U.S. Food and Drug Administration (FDA) has cleared the company’s...
Advertisements
Charles River and Medigen Advance Vaccine Development With NGS
Wilmington, Massachusetts, August 20, 2026 Charles River Laboratories International and Medigen Vaccine Biologics Corp. (MVC) have entered into a...
Genprex Advances Diabetes Gene Therapy Manufacturing Scale-Up
AUSTIN, Texas, August 18, 2026 Genprex, Inc. has entered into a development and manufacturing agreement with a leading U.S.-based...
Estrigenix Therapeutics Secures Seed Funding to Advance ERβ Platform
MILWAUKEE, July 21, 2026 Estrigenix Therapeutics announced the first closing of its $2 million Series Seed financing, led by...
Atsena Selects ATSN-401 for Stargardt Disease
DURHAM, N.C., July 9, 2026 Atsena Therapeutics announced the selection of ATSN-401 as its lead clinical candidate for the...
ARTAN Bio Secures $1M Seed Round for tRNA Platform
ST. PETERSBURG, Fla., July 1, 2026 ARTAN Bio has announced the successful completion of a $1 million seed financing...
Advertisement
